2 super dividend yields that could make you stinking rich

Forgetting about growth and investing for dividends could be the best strategy in these troubled times.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investors have been waiting for a Marks & Spencer Group (LSE: MKS) turnaround for years now, but they seem to be forever disappointed. Are we expecting the wrong thing?

Earnings per share have pretty much remained flat in recent years, from 31.9p in 2013 to a barely unmoved 30.4p for the year ended April 2017. We have 28p-29p pencilled-in for the next couple of years, putting the 331p shares on P/E multiples of 11 to 12.

First-quarter results released Tuesday paint a familiar picture. At £2,532m, total revenue for the period showed a 2.7% rise, with UK revenue of £2,259m up 2.6%. Food revenue rose by 4.5%, but Clothing & Home is still struggling to turn itself around with a 0.5% drop — and  total like-for-like UK revenue slipped by 0.5%, with Clothing & Home down 1.2%.

Should you invest £1,000 in Marks and Spencer right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Marks and Spencer made the list?

See the 6 stocks

Improving margins?

On the up side, Clothing & Home full-price sales were up around 7% (and no clearance sale, as there was a year ago), so those broadly flat sales might even convert to an improvement in profit.

M&S has been opening more Simply Food outlets too, and concentrating on what you do best is a good strategy in my book.

That brings me to my alternative view of the company. If, instead of looking for a recovery stock and expecting a turnaround to steady earnings growth, I consider M&S as a plodding but stable payer of dividends, I see it in a different light.

Dividends have grown a little, from 17p in 2013 to 18.7p, and there are slight rises forecast between now and 2019. With the share price having fallen over the past couple of years, we’re looking at yields of around 5.6%. That looks good to me.

Steady cash

Although I generally don’t like investing in managed funds, buying shares of the companies running them can be very profitable — and I’m a big fan of investment trusts, which have a number of advantages. One is the flexibility they enjoy over handing out cash to shareholders, enabling them to maintain a reliable long-term dividend plan.

That’s precisely what MedicX Fund (LSE: MXF), set to soon convert to a real estate investment trust, has been doing. The company invests in purpose-built primary healthcare properties, mostly GP practices and pharmacies — and that provides steady NHS-guaranteed rental income, often with inflation-linked rises.

The first half of the current year saw a 5.1% rise in rent receivable, which is well ahead of inflation, and that should help the firm to an anticipated full-year dividend of 6p per share under its progressive dividend policy.

On today’s share price of 89.5p, that would amount to a very nice yield of 6.7%.

Sufficient cover?

The only apparent downside is an underlying dividend cover of only 70%, but there are a couple of things that should offset that worry. Firstly, MedicX offers a scrip dividend scheme, and the cash doesn’t need to be found for those taking their dividends as shares (which is surely the best thing to do for long-term gain).

The company says it is “committed to increasing dividend cover over time“, and points out that cover at any one time depends on “the balance between debt and equity capital and the number of assets under construction“. A planned debt drawdown to fund some Irish developments should increase cover too.

I see MedicX’s dividends as reliable, and I think the shares are attractively priced.

But this isn’t the only opportunity that’s caught my attention this week. Here are:

5 Shares for the Future of Energy

Investors who don’t own energy shares need to see this now.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.

While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.

Open this new report5 Shares for the Future of Energy — and discover:

  • Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
  • How to potentially get paid by the weather
  • Electric Vehicles’ secret backdoor opportunity
  • One dead simple stock for the new nuclear boom

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

£10,000 invested in Lloyds shares on 7 April is already worth…

After a dip in early April, Lloyds shares are back to their 30%+ year-to-date gain in 2025. And analysts are…

Read more »

US Stock

What I’d look to buy as the US stock market heads for the worst month since 1932

Jon Smith sifts through the US stock market to try and find some ideas that have fallen in value recently…

Read more »

Growth Shares

Prediction: I think £1,000 invested in this UK stock could double by 2030

Jon Smith runs through a FTSE 250 stock with a market cap just over £1bn that he feels has the…

Read more »

Investing Articles

With £10k in savings, here’s how an investor could target a second income of £500 a month

£10k in savings could be the foundation needed towards a powerful second income. Our writer details some steps necessary to…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing For Beginners

£1k invested in the FTSE 100 on ‘Liberation Day’ is now worth…

Jon Smith talks about the volatility in the FTSE 100 in the weeks since the tariff announcements and flags up…

Read more »

Long-term vs short-term investing concept on a staircase
Investing Articles

Barclays’ share price is down 7% from March, so is now the right time for me to buy?

Barclays’ share price has dipped recently, which could mean a bargain to be had. I took a deep dive into…

Read more »

Investing Articles

Down 13% since March, does this rising FTSE 250 defence star look an unmissable buy for me?

The FTSE 250 is currently home to many of the big stock stars of tomorrow and I think this high-tech…

Read more »

Investing Articles

Should I buy Aston Martin shares for my ISA while they’re under 70p?

With Aston Martin's shares down hugely across multiple time frames, this writer is wondering if he should snap up some…

Read more »